Sanjiv Sam Gambhir is a Professor of Radiology and Bioengineering at Stanford University, Head of Nuclear Medicine, and Director of the Molecular Imaging Program at Stanford (MIPS). He has developed many strategies for imaging basic cell/molecular events including signal transduction, gene expression, and cell trafficking. Dr. Gambhir also has extensive experience with clinical FDG PET and has developed many of the management algorithms for cancer patients including cost-effectiveness models. Dr. Gambhir's translational laboratory focuses on molecular imaging, specifically new probe development for positron emission tomography (PET) and multimodality molecular imaging including the use of optical imaging. His laboratory has developed methods to image gene/cell therapy in living subjects including humans.

He recently received the 2006 Hounsfield Medal, 2004 gold medal award by the Society of Molecular Imaging, the 2004 distinguished scientist award by the Academy of Molecular Imaging, and the 2003 Holst Medal for his contributions to the field of molecular imaging. He is President of the Academy of Molecular Imaging (AMI) and associate editor of several journals.

Mark Davis
Warren and Katharine Schlinger Professor of Chemical Engineering
Member Experimental Therapeutics Program
Comprehensive Cancer Center, City of Hope
California Institute of Technology

Mark E. Davis is the Warren and Katharine Schlinger Professor of Chemical Engineering at the California Institute of Technology and a member of the Experimental Therapeutics Program of the Comprehensive Cancer Center at the City of Hope. Professor Davis’ research efforts involve materials synthesis in two general areas; zeolites and other solids that can be used for molecular recognition and catalysis, and polymers for the delivery of macromolecular therapeutics such as nucleic acids.

Professor Davis founded Insert Therapeutics Inc., a company based in Pasadena, CA, focused on the use of cyclodextrin-containing polymers for drug delivery applications and Calando Pharmaceuticals, Inc. a company based in Duarte, CA that creates RNAi therapeutics. He has authored two textbooks, over 325 scientific publications, and holds over 40 patents. Professor Davis is a founding editor of CaTTech and has been an associate editor of Chemistry of Materials and the AIChE Journal. His awards include the Colburn and Professional Progress Awards from the AIChE and the Ipatieff, Langmuir and Murphree Prizes from the ACS. Professor Davis was the first engineer to win the NSF Alan T. Waterman Award. He was elected in the National Academy of Engineering in 1997 and the National Academy of Sciences in 2006.